Hormone/Antihormone Withdrawal and Dexamethasone for Hormone‐Refractory Prostate Cancer

Abstract

In treating hormone-refractory advanced prostate cancer, the first pharmacologic manipulation should be withdrawal of the oral component of combined hormonal therapy. Patients whose disease progresses after hormone withdrawal should then be treated with glucocorticoids such as dexamethasone.